Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. - Test2 - elhamkhani - TriplyDB

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

http://www.wikidata.org/entity/Q34044753

about

Screening for Prostate Cancer: Shaping the Debate on Benefits and Harms Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.Prostate MRI - an update for the referring urologist Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review Current role of multiparametric magnetic resonance imaging for prostate cancer Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis Health screening for older people-what are the current recommendations?Kallikreins as biomarkers for prostate cancer Urinary biomarkers for prostate cancer Prostate cancer: ESMO Consensus Conference Guidelines 2012 Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Prostate cancer screening in Brazil: should it be done or not?Multiparametric-MRI in diagnosis of prostate cancer Increased Dietary Inflammatory Index (DII) Is Associated With Increased Risk of Prostate Cancer in Jamaican Men A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer More Is Not Always Better: Intuitions About Effective Public Policy Can Lead to Unintended Consequences Image registration for targeted MRI-guided transperineal prostate biopsy Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues.Prostate specific antigen: the past, present and future.Discussing uncertainty and risk in primary care: recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution Correlated diffusion imaging.Prostate cancer screening: a complicated puzzle, explanation needed Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohort Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Impact of patient navigation on timely cancer care: the Patient Navigation Research Program Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.Screening for prostate cancer: the debate continues Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease.A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data

P2860

Q24197953-E72D12E1-311B-4F04-A8F2-404ABEFA404D Q24620320-A89C9AC4-FE41-4803-97FD-03B27DCE0BE4 Q26739725-72038F00-AA98-4A09-A7CA-C42F8723E59F Q26742027-5E24828A-9359-4672-A130-927556708D39 Q26748873-A2107548-CD85-4390-B7C0-870481106ED6 Q26774839-8E61434C-A259-4CB9-8EC8-50756AFFEB56 Q26781093-5306E3F5-7118-4DD0-88E5-21D768BA8CD1 Q26783443-79FA39D8-DD46-471F-B970-86ECA0C09AE0 Q26862434-0BAB46CB-9036-4974-9709-1317FAA197CB Q27009110-7AAFD252-A81C-4801-9941-E406679DB31C Q27022847-20355140-CF2B-41F9-AD8F-9BD73348745D Q27852185-97EEAB67-8A14-4E91-B204-5D325FB661C3 Q28068688-EA27D8C4-9497-457A-8BFA-79880DDE9975 Q28081873-411F3125-ED63-4CAA-B265-6A19E2781366 Q28390566-3F1155E6-5A66-4485-A7A4-D6806F62125E Q28652628-5B6E2CDD-5DEC-4C87-8CF2-FB353ADFAE5E Q28681293-DFCFFEEC-EB43-4BC5-BE45-292E273EEA48 Q28728052-E1190FDD-EA08-46D7-9B2F-134DCD7FF6E2 Q30395328-719C982A-081F-4232-A936-C83BF1993EBC Q30436923-AC3EE5E6-F8A9-4DE6-88E9-AFD4523A731B Q30551064-AFC7BC61-2BA9-4CFF-AF65-819D1021BFF1 Q30577573-B47AF25B-21FD-4596-B8C4-7F121CE37107 Q30613075-967683D8-19F1-4231-9143-E452EA5473E4 Q30621928-702DA09E-DF75-40DB-865A-9FE96757A9A6 Q30660148-4C6F6F8E-0D39-4C69-8146-0D8F541700AE Q33356114-83883533-6974-49A9-AD22-6B1B6F3E3322 Q33643656-573EE181-A1BE-4937-A420-4E09D775F13C Q33693397-762CFEDF-7E6E-4EDC-8040-5BE2A088E639 Q33739897-094FB113-4ED5-4B62-9009-86A9EAB10280 Q33750148-63332CB3-3F3A-4981-B947-4D6441604052 Q33813179-0B9EB818-97C0-4FDD-AB6F-D0B4332B9315 Q33836709-B81297DF-9166-45DC-B985-A7E311BA98BA Q33862301-1825CEA6-62CD-470E-8175-4E9074D22093 Q33883502-5AD863E5-62E5-4A6A-A8F4-6244BEDA826E Q33885776-630A664C-1694-4139-8CE2-F20247CE3F10 Q34136485-43173F54-661F-4802-993D-C14F841331AB Q34152258-B4446612-2265-4907-A8EC-1E4FC3CAA19F Q34171768-04B29EE0-1C1D-4A38-9A57-0E34A199DC28 Q34294196-7BF630AA-1150-43B7-ABE5-ACD2D20929E7 Q34382946-3D7CD817-FA15-4996-B6F7-12C629E02CC6

P2860

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

http://www.wikidata.org/entity/Q34044753

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Screening for prostate cancer: ...... reventive Services Task Force.

@ast

Screening for prostate cancer: ...... reventive Services Task Force.

@en

Screening for prostate cancer: ...... reventive Services Task Force.

@nl

type

label

Screening for prostate cancer: ...... reventive Services Task Force.

@ast

Screening for prostate cancer: ...... reventive Services Task Force.

@en

Screening for prostate cancer: ...... reventive Services Task Force.

@nl

prefLabel

Screening for prostate cancer: ...... reventive Services Task Force.

@ast

Screening for prostate cancer: ...... reventive Services Task Force.

@en

Screening for prostate cancer: ...... reventive Services Task Force.

@nl

P1433

Q34044753-55A9AC75-ECA8-4D3F-BD34-63AE01336043

P1476

Q34044753-B47DCA26-6B48-4164-A06E-4AF23BF02CAF

P2093

Q34044753-02E913A5-390B-442F-9F5F-82D11A6BA806

Q34044753-130338B9-07F5-4A84-BAB3-DC7AF02F3382

Q34044753-16D48563-165F-4BE6-A16A-40E085E07933

Q34044753-4C5F6C00-D216-41BF-9FFD-768FB2A23EF1

Q34044753-4F19AF97-7322-42DF-99F5-03D5F569899A

Q34044753-5C98F844-9A9F-493C-A547-E110B68B1BA2

Q34044753-6707ECEA-4934-4F8A-9369-127049C0DBCA

Q34044753-76AD466A-0CEA-4200-A9D3-E5998B147C46

Q34044753-8362EDD7-B361-47EB-806A-0DD7315877DA

Q34044753-86DF6D42-7797-4AA5-8307-25168B321501

P304

Q34044753-FC0F514D-FCBE-43CC-9F6A-3B8FAD8F4830

P31

Q34044753-FCCAE023-8EDC-4558-B5C2-C3E17D89423B

P356

Q34044753-23BFECD6-5A96-4499-91C6-FBD5FD70A86D

P407

Q34044753-AF286330-02DE-4C0D-A9D2-C7C4BA3E43D3

P433

Q34044753-DB600F6E-B524-4DB5-ADC8-6E8E30A2A344

P478

Q34044753-092A907C-D078-40BA-B6DA-8291937796EF

P577

Q34044753-D1F87B2A-95E5-4F66-9F08-B80C7435088D

P698

Q34044753-26868C46-52AD-4468-B210-5F00CA1C3245

P356

0003-4819-155-11-201112060-00375

P1433

Annals of Internal Medicine

P1476

Screening for prostate cancer: ...... reventive Services Task Force.

@en

P2093

Ashley Maltz

http://www.w3.org/2001/XMLSchema#string

Christina Bougatsos

http://www.w3.org/2001/XMLSchema#string

Clarence Lam

http://www.w3.org/2001/XMLSchema#string

Helen C Koenig

http://www.w3.org/2001/XMLSchema#string

Ian Blazina

http://www.w3.org/2001/XMLSchema#string

J Bruin Rugge

http://www.w3.org/2001/XMLSchema#string

Jennifer M Croswell

http://www.w3.org/2001/XMLSchema#string

Ken Gleitsmann

http://www.w3.org/2001/XMLSchema#string

Kenneth Lin

http://www.w3.org/2001/XMLSchema#string

Roger Chou

http://www.w3.org/2001/XMLSchema#string

P304

762-771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-155-11-201112060-00375

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21984740

http://www.w3.org/2001/XMLSchema#string